VivoSim Labs (VIVS) EBIT (2010 - 2026)
VivoSim Labs (VIVS) posted quarterly EBIT of -$3.2 million for Q1 2026, down 1.05% year-over-year from -$3.2 million in Q1 2025, and down 15.89% quarter-over-quarter from -$2.8 million in Q4 2025.
VivoSim Labs (VIVS) EBIT (2010 - 2026) Analysis & Trends
VivoSim Labs' EBIT history runs 17 years deep, the most recent figure standing at -$3.2 million for Q1 2026.
- In Q1 2026, EBIT fell 1.05% year-over-year to -$3.2 million; the TTM figure through Mar 2026 stood at -$11.5 million (up 8.95% YoY), while the FY2026 annual figure was -$11.5 million, up 8.95% from the prior year.
- EBIT for Q1 2026 stood at -$3.2 million, down from -$2.8 million in the prior quarter.
- The five-year high for EBIT was -$1.9 million in Q1 2022, with the low at -$7.8 million in Q1 2023.
- The 5-year median for EBIT is -$3.2 million (2022), against an average of -$3.5 million.
- The sharpest annual moves came in 2023 and 2024: EBIT sank 306.64% in 2023, then surged 60.2% in 2024.
- VivoSim Labs' EBIT stood at -$3.4 million in 2022, then slipped by 9.56% to -$3.7 million in 2023, then advanced by 5.76% to -$3.5 million in 2024, then rose by 20.7% to -$2.8 million in 2025, then declined by 15.89% to -$3.2 million in 2026.
- Business Quant data shows VIVS's EBIT at -$3.2 million in Q1 2026, -$2.8 million in Q4 2025, and -$2.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 231.44 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.55 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 133.12 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -375.75 Mn |
| 10 | VivoSim Labs | 1.46 Mn | 1.46 Mn | - | -2.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.76 Mn |
| Mar 31, 2026 | -3.19 Mn |
| Dec 31, 2025 | -2.75 Mn |
| Sep 30, 2025 | -2.64 Mn |
| Jun 30, 2025 | -2.92 Mn |
| Mar 31, 2025 | -3.15 Mn |
| Dec 31, 2024 | -3.47 Mn |
| Sep 30, 2024 | -2.61 Mn |
| Jun 30, 2024 | -3.39 Mn |
| Mar 31, 2024 | -3.10 Mn |
| Dec 31, 2023 | -3.68 Mn |
| Sep 30, 2023 | -4.12 Mn |
| Jun 30, 2023 | -4.20 Mn |
| Mar 31, 2023 | -7.78 Mn |
| Dec 31, 2022 | -3.36 Mn |
| Sep 30, 2022 | -3.35 Mn |
| Jun 30, 2022 | -3.24 Mn |
| Mar 31, 2022 | -1.91 Mn |
| Dec 31, 2021 | -3.50 Mn |
| Sep 30, 2021 | -3.51 Mn |